drug

delta 9 tetrahydrocannabinol

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Yale University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Investigational (via trials)
SchizophreniaCOMT Gene Polymorphism

Trials

1
Pharmacogenetics of Cannabinoid Response
NCT00678730Early Phase 1Completed

KOLs & investigators

1
Deepak C D'Souza, M.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Yale University
company
trial
Pharmacogenetics of Cannabinoid Response
EARLY_PHASE1
trial
indication
Schizophrenia
indication
COMT Gene Polymorphism
indication
KOL
Deepak C D'Souza, M.D.
KOL score 5
person